カテゴリー： Grand View Research, 世界, 医療/バイオ

空間ゲノミクス＆トランスクリプトミクスの世界市場2023-2030：市場規模、シェア、動向分析

◆英語タイトル：Spatial Genomics & Transcriptomics Market Size, Share & Trends Analysis Report By Technology (Spatial Transcriptomics, Spatial Genomics), By Product (Consumables, Software), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23AUG015）◆商品コード：GRV23AUG015
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年7月25日
◆ページ数：180
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：バイオ技術
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

空間ゲノミクス＆トランスクリプトミクス市場の成長と動向
Grand View Research社の最新レポートによると、世界の空間ゲノミクス＆トランスクリプトミクス市場規模は2030年までに5億7430万米ドルに達する見込みです。2023年から2030年までのCAGRは12.2%で成長する見込みです。同市場は、がん検出法としての空間ゲノム解析の可能性の高まりと、最新世代のシーケンス技術の登場により、予測期間中に大きく成長する見通しです。

個人の特性に基づいてオーダーメイドの医療を提供することを目指す個別化医療へのシフトが、空間ゲノミクス＆トランスクリプトミクスの需要を促進しています。これらの技術は、患者組織内の遺伝的・分子的状況を包括的に把握し、正確な診断、予後予測、治療法の選択を可能にします。空間ゲノミクス＆トランスクリプトミクスは、疾患のサブタイプに関連する特定の遺伝子発現パターンの同定を容易にし、臨床医が個別化された治療戦略について十分な情報に基づいた意思決定を行うことを可能にします。

空間ゲノミクス＆トランスクリプトミクスの市場は、近年著しい技術進歩を遂げています。各社は、空間ゲノミクス＆トランスクリプトミクス・プラットフォームの精度、拡張性、手頃な価格を改善するための研究開発に投資しています。さらに、データ解析と解釈を簡素化するユーザーフレンドリーな統合ソリューションの登場により、これらの技術はより幅広いユーザー層にとって利用しやすいものとなっています。

例えば、Vizgen社は2023年4月、MERFISH技術に基づく世界初のシングルセル空間ゲノミクス・プラットフォームを発表しました。この装置は、トランスクリプトームをプロファイリングするための高解像度と最大限の効率を提供します。これらの進歩は市場の可能性を拡大し、学術界と産業界の両方から投資を集めています。

空間ゲノミクス＆トランスクリプトミクス市場レポートハイライト

- 空間トランスクリプトミクス技術セグメントは、単一細胞のトランスクリプトミクス研究において、空間ゲノム法と比較して高い採用率により、2022年に最大の収益シェアを占めました。

- 消耗品セグメントは、予測期間中に最も速いCAGRで成長する見込みです。このセグメントは、サンプル調製から結果導出まで、ゲノムマッピングのさまざまな段階にわたって機器を稼働させるために必要な製品をカバーしているからです。

- トランスレーショナルリサーチセグメントは、2022年に最も高い売上シェアを占めました。トランスレーショナルリサーチにおける空間オミックス技術の使用は、生理学と疾患の状態の徹底的な分析を提供することにより、研究に利益をもたらす可能性があるためです。

- アジア太平洋地域は、中国とインドの新興経済圏に未開拓の機会が存在するため、予測期間中に最も速いCAGRで成長すると予測されています。

- 主な市場参入企業には、Natera Inc.、10x Genomics、Dovetail Genomics、Illumina, Inc.、S2 Genomics, Inc.などがあります。

第1章. 調査手法＆範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 技術別分析
第5章. 製品別分析
第6章. エンドユーズ別分析
第7章. 地域別分析
第8章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Emerging potential of spatial genomic analysis as a cancer diagnostic tool
3.2.1.2. Advent of the fourth generation of sequencing (in situ sequencing)
3.2.1.3. Emerging players can boost the market competitiveness
3.2.2. Market Restraint Analysis
3.2.2.1. Slow implementation of technology
3.2.2.2. Well-established workflows for conventional genomics & transcriptomics analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. Spatial Genomics & Transcriptomics Market: Technology Movement Analysis
4.2. Spatial Transcriptomics
4.2.1. Global Spatial Transcriptomics Market, 2018 – 2030 (USD Million)
4.2.2. Sequencing-based methods
4.2.2.1. Global sequencing-based methods Market, 2018 – 2030 (USD Million)
4.2.2.2. Laser Capture Microdissection (LCM)
4.2.2.2.1. Global LCM market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.2.2.2.2. LCM using FFPE Tissue Samples
4.2.2.2.2.1. Global FFPE tissue samples-based LCM market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.2.2.2.3. LCM using other Tissue Samples
4.2.2.2.3.1. Global other tissue samples-based LCM market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.2.2.3. Transcriptome In-vivo Analysis (TIVA)
4.2.2.3.1. Global TIVA market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.2.2.4. In situ sequencing
4.2.2.4.1. Global In situ sequencing market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.2.2.5. Microtomy sequencing
4.2.2.5.1. Global microtomy sequencing market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.2.3. IHC
4.2.3.1. Global IHC Market, 2018 – 2030 (USD Million)
4.2.4. Microscopy-based RNA imaging techniques
4.2.4.1. Global microscopy-based RNA imaging techniques Market, 2018 – 2030 (USD Million)
4.2.4.2. Single Molecule RNA fluorescence In-Situ Hybridization (smFISH)
4.2.4.2.1. Global Single Molecule RNA fluorescence In-Situ Hybridization (smFISH) market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.2.4.3. Padlock Probes/Rolling Circle Amplification
4.2.4.3.1. Global Padlock Probes/Rolling Circle Amplification market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.2.4.4. Branched DNA Probes
4.2.4.4.1. Global Branched DNA probes market for spatial transcriptomics, 2018 – 2030 (USD Million)
4.3. Spatial Genomics
4.3.1. Global spatial genomics Market, 2018 – 2030 (USD Million)
4.3.2. FISH
4.3.2.1. Global FISH Market for spatial genomics, 2018 – 2030 (USD Million)
4.3.3. Microscopy-based Live DNA Imaging
4.3.3.1. Global Microscopy-based Live DNA Imaging Market for spatial genomics, 2018 – 2030 (USD Million)
4.3.4. Genome Perturbation tools
4.3.4.1. Global genome perturbation tools Market for spatial genomics, 2018 – 2030 (USD Million)
4.3.5. Massively-Parallel Sequencing
4.3.5.1. Global massively-parallel sequencing Market for spatial genomics, 2018 – 2030 (USD Million)
4.3.6. Biochemical Techniques
4.3.6.1. Global biochemical techniques Market for spatial genomics, 2018 – 2030 (USD Million)
4.3.7. Others
4.3.7.1. Global others Market for spatial genomics, 2018 – 2030 (USD Million)
Chapter 5. Product Business Analysis
5.1. Spatial Genomics & Transcriptomics Market: Product Movement Analysis
5.2. Instruments
5.2.1. Global Instruments Market for Spatial Genomics & Transcriptomics, 2018 – 2030 (USD Million)
5.2.2. By Mode
5.2.2.1. Automated
5.2.2.1.1. Global automated Market, 2018 – 2030 (USD Million)
5.2.2.2. Semi-Automated
5.2.2.2.1. Global semi-automated Market, 2018 – 2030 (USD Million)
5.2.2.3. Manual
5.2.2.3.1. Global manual Market, 2018 – 2030 (USD Million)
5.2.3. By Type
5.2.3.1. Sequencing Platforms
5.2.3.1.1. Global sequencing platforms Market, 2018 – 2030 (USD Million)
5.2.3.2. IHC
5.2.3.2.1. Global IHC Market, 2018 – 2030 (USD Million)
5.2.3.3. Microscopy
5.2.3.3.1. Global microscopy Market, 2018 – 2030 (USD Million)
5.2.3.4. Flow Cytometry
5.2.3.4.1. Global flow cytometry Market, 2018 – 2030 (USD Million)
5.2.3.5. Mass Spectrometry
5.2.3.5.1. Global mass spectrometry Market, 2018 – 2030 (USD Million)
5.2.3.6. Others
5.2.3.6.1. Global others Market, 2018 – 2030 (USD Million)
5.3. Consumables
5.3.1. Global consumables Market for Spatial Genomics & Transcriptomics, 2018 – 2030 (USD Million)
5.4. Software
5.4.1. Global software Market for Spatial Genomics & Transcriptomics, 2018 – 2030 (USD Million)
5.4.2. Bioinformatics Tools
5.4.2.1. Global bioinformatics tools Market for Spatial Genomics & Transcriptomics, 2018 – 2030 (USD Million)
5.4.3. Imaging Tools
5.4.3.1. Global imaging tools Market for Spatial Genomics & Transcriptomics, 2018 – 2030 (USD Million)
5.4.4. Storage and Management Databases
5.4.4.1. Global storage and management databases Market for Spatial Genomics & Transcriptomics, 2018 – 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Spatial Genomics & Transcriptomics Market: End-use Movement Analysis
6.2. Translational Research
6.2.1. Global spatial genomics & transcriptomics-based translational research market, 2018 – 2030 (USD Million)
6.3. Academic Customers
6.3.1. Global spatial genomics & transcriptomics-based academic customers market, 2018 – 2030 (USD Million)
6.4. Diagnostic Customers
6.4.1. Global spatial genomics & transcriptomics-based diagnostic customers market, 2018 – 2030 (USD Million)
6.5. Pharmaceutical Manufacturer
6.5.1. Global spatial genomics & transcriptomics-based pharmaceutical manufacturer market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Spatial Genomics & Transcriptomics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. UK Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Germany Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. France Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Italy Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Spain Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Denmark Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Sweden Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Norway Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Japan Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. China Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. India Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Australia Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Thailand Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. South Korea Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Brazil Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Mexico Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Argentina Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. South Africa Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Saudi Arabia Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. UAE Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Kuwait Spatial Genomics & Transcriptomics Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Natera, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. 10x Genomics
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Dovetail Genomics
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Illumina, Inc.
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. S2 Genomics, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Nanostring Technologies, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Seven Bridges Genomics
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Horizon Discovery Group plc
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Bio-Techne
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 3 Global Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 4 Global Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 5 Global Spatial Genomics & Transcriptomics Market, by region, 2018 - 2030 (USD Million)
Table 6 North America Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 8 North America Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 9 North America Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 10 U.S. Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 11 U.S. Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 12 U.S. Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 13 Canada Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 14 Canada Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 15 Canada Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 16 Europe Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
Table 17 Europe Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 18 Europe Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 19 Europe Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 20 UK Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 21 UK Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 22 UK Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 23 Germany Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 24 Germany Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 25 Germany Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 26 France Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 27 France Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 28 France Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 29 Italy Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 30 Italy Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 31 Italy Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 32 Spain Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 33 Spain Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 34 Spain Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 35 Denmark Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 36 Denmark Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 37 Denmark Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 38 Sweden Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 39 Sweden Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 40 Sweden Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 41 Norway Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 42 Norway Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 43 Norway Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 48 Japan Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 49 Japan Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 50 Japan Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 51 China Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 52 China Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 53 China Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 54 India Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 55 India Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 56 India Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 57 Australia Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 58 Australia Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 59 Australia Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 60 Thailand Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 61 Thailand Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 62 Thailand Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 63 South Korea Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 64 South Korea Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 65 South Korea Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 66 Latin America Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
Table 67 Latin America Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 68 Latin America Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 69 Latin America Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 70 Brazil Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 71 Brazil Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 72 Brazil Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 73 Mexico Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 74 Mexico Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 75 Mexico Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 76 Argentina Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 77 Argentina Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 78 Argentina Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Spatial Genomics & Transcriptomics Market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 83 South Africa Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 84 South Africa Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 85 South Africa Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 89 UAE Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 90 UAE Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 91 UAE Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)
Table 92 Kuwait Spatial Genomics & Transcriptomics Market, by Product, 2018 - 2030 (USD Million)
Table 93 Kuwait Spatial Genomics & Transcriptomics Market, by Technology, 2018 - 2030 (USD Million)
Table 94 Kuwait Spatial Genomics & Transcriptomics Market, by End-use, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 空間ゲノミクス＆トランスクリプトミクスの世界市場2023-2030：市場規模、シェア、動向分析(Spatial Genomics & Transcriptomics Market Size, Share & Trends Analysis Report By Technology (Spatial Transcriptomics, Spatial Genomics), By Product (Consumables, Software), By End-use, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 空間ゲノミクス＆トランスクリプトミクスの世界市場2022年～2029年：技術別、製品別、エンドユーザー別、地域別
  • 睡眠モニタリング用フィットネストラッカーの世界市場2023-2030：市場規模、シェア、動向分析
  • 世界のカスタム抗体市場2023-2030：市場規模、シェア、動向分析
  • 世界のアデノ随伴ウイルス（AAV）ベクター製造市場2023-2030：市場規模、シェア、動向分析
  • 微生物APIの世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆